BioSpace News Archive

MoonLake Immunotherapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update.

Viatris Inc., a global healthcare company, announced the company will participate in the Jefferies London Healthcare Conference in London, UK on Wednesday, November 15, 2023.

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized the repurchase of $4 billion of shares of its common stock in the open market or in negotiated transactions.

Agilent Technologies Inc. (NYSE: A) today announced that it has received FDA approval for the use of PD-L1 IHC 22C3 pharmDx as a diagnostic tool to aid in identifying patients with Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma who may be eligible for treatment with KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy.

GeneCentric Therapeutics today announced the appointment of Prasanth Reddy, MD, MPH, FACP, and Don Hardison as independent directors of its Board of Directors.

UroGen Pharma Ltd. today announced financial results for the third quarter ended September 30, 2023, and provided an overview of recent developments.

Institute of Biomedical Research Corp., a vanguard entity at the forefront of nutraceutical biotechnology specializing in alternative plant-based cannabinoids, medical psilocybin, and cutting-edge mental health therapeutic research driven by artificial intelligence, is pleased to provide the following update:

Jaguar Health, Inc. today reported consolidated third-quarter 2023 financial results and provided Company updates.

Twist Bioscience Corporation today announced the launch of Twist Express Genes, a new leading gene synthesis service with an order to shipping turnaround time of five to seven business days.1

NImmune Biopharma will be presented at the American College of Rheumatology’s (ACR) annual meeting. ACR Convergence 2023 will take place from November 10-15, 2023, at the San Diego Convention Center in San Diego, California, with NImmune’s poster presentation to take place on Tuesday, November 14 from 9:00 am – 11:00 am.